Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial
Autor: | Alessandro Rambaldi, Carola Boccomini, Atto Billio, Francesco Angrilli, Roberto Passera, Marco Ladetto, Francesco Zallio, Gianpietro Semenzato, Liliana Devizzi, Fabio Ciceri, Barbara Mantoan, Fausto Rossini, Alessandra Dondi, Alessandra Tucci, Fabio Benedetti, Caterina Stelitano, Delia Rota-Scalabrini, Valerio Zoli, Paolo Corradini, Riccardo Bruna, Corrado Tarella, Maurizio Musso, Franco Narni, Caterina Patti, Guido Gini, Claudia Castellino, Tommasina Perrone, Anna Maria Barbui, Francesco Lanza, Anna Marina Liberati, Guido Parvis, Francesco Di Raimondo, Alessandro Massimo Gianni, Alessandro Pulsoni, Angela Gueli |
---|---|
Přispěvatelé: | Bruna R., Benedetti F., Boccomini C., Patti C., Barbui A. M., Pulsoni A., Musso M., Liberati A. M., Gini G., Castellino C., Rossini F., Ciceri F., Rota-Scalabrini D., Stelitano C., Di Raimondo F., Tucci A., Devizzi L., Zoli V., Zallio F., Narni F., Dondi A., Parvis G., Semenzato G., Lanza F., Perrone T., Angrilli F., Billio A., Gueli A., Mantoan B., Rambaldi A., Massimo Gianni A., Corradini P., Passera R., Ladetto M., Tarella C., Bruna, R., Benedetti, F., Boccomini, C., Patti, C., Barbui, A. M., Pulsoni, A., Musso, M., Liberati, A. M., Gini, G., Castellino, C., Rossini, F., Ciceri, F., Rota-Scalabrini, D., Stelitano, C., Di Raimondo, F., Tucci, A., Devizzi, L., Zoli, V., Zallio, F., Narni, F., Dondi, A., Parvis, G., Semenzato, G., Lanza, F., Perrone, T., Angrilli, F., Billio, A., Gueli, A., Mantoan, B., Rambaldi, A., Massimo Gianni, A., Corradini, P., Passera, R., Ladetto, M., Tarella, C. |
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Male
Oncology Lymphoma medicine.medical_treatment advanced-stage follicular lymphoma Follicular lymphoma Kaplan-Meier Estimate law.invention 0302 clinical medicine Cancer immunotherapy Randomized controlled trial Recurrence immune system diseases law hemic and lymphatic diseases Antineoplastic Combined Chemotherapy Protocols Prospective cohort study Lymphoma Follicular non-Hodgkin lymphoma Remission Induction Hematology Middle Aged Prognosis Combined Modality Therapy Treatment Outcome Italy chemoimmunotherapy Female Rituximab Adult Follow-Up Studies Humans Neoplasm Staging Proportional Hazards Models Young Adult medicine.drug medicine.medical_specialty Sudden death Article NO 03 medical and health sciences Lymphoma therapy clinical trial Internal medicine medicine Cancer staging Chemotherapy business.industry Follicular medicine.disease business 030215 immunology |
Zdroj: | Haematologica |
Popis: | A prospective trial conducted in the period 2000-2005 showed no survival advantage for high-dose chemotherapy with rituximab and autograft (R-HDS) versus conventional chemotherapy with rituximab (CHOP-R) as first-line therapy in 134 high-risk follicular lymphoma patients aged |
Databáze: | OpenAIRE |
Externí odkaz: |